CarolLippaMD
Neurology • Philadelphia, PAMovement Disorder, Neurodegenerative, Dementia & Geriatrics
Director, Cognitive Disorders and Comprehensive Alzheimer's Disease Center at Thomas Jefferson University. Director, Division of Cognitive Disorders, Department of Neurology.
Dr. Lippa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Walnut St
Philadelphia, PA 19107Phone+1 215-955-1234Fax+1 215-923-6792
Summary
- Board certified neurologist with an international reputation in academic neurology, who has directed cognitive disorders programs for over 20 years. Currently bringing together experts from various disciplines to develop a Cognitive and Comprehensive Alzheimer’s disease clinical, research and education Center within the Farber Institute for Neuroscience and TJU department of Neurology to provide patients and families more accurate and earlier diagnosis and intervention, expand and solidify the related translational research units and develop education/training initiatives.
Clinical Expertise
- Alzheimer's disease, Alzheimer Vaccines, Vascular dementia, Lewy body dementia, Parkinson's disease, Frontotemporal lobar degeneration , Cognitive disorders, Concussion, Clinical research, Clincial trials, Behavioral neurology / Neuropsychiatry, General neurology, Geriatrics / Dementia, Movement disorders, Depressed skull fractures, Post-partum depression, Sexual aversion disorder, Diabetes
Education & Training
University of Massachusetts Medical SchoolFellowship, Neuropathology, 1987 - 1988- UMass Chan Medical SchoolResidency, Neurology, 1983 - 1987
- University of Massachusetts Medical SchoolClass of 1983
Certifications & Licensure
NJ State Medical License 2018 - 2025
PA State Medical License 1995 - 2024
MA State Medical License 1988 - 2005- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia Start of enrollment: 2006 Nov 01
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAssociation of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies.David G Coughlin, Karen R MacLeod, John S Middleton, Andrea C Bozoki, James E Galvin
Neurology. 2024-08-13 - 2 citationsMetabolic and Environmental Biomarkers in Mild Cognitive Impairment and Dementia: An Exploratory Study.Abigail C Lyon, Carol F Lippa, Arnold R Eiser
Journal of Integrative and Complementary Medicine. 2024-08-01 - 2 citationsTolerability of memantine monotherapy versus adding memantine as combination therapy.Estevana Isaac, David Ney, Mijail Serruya, Scott Keith, Carol Lippa
Journal of the National Medical Association. 2022-06-01
Press Mentions
Health: Cocoa & the Brain, Restoring Your Younger MindMay 6th, 2016
Grant Support
- International Multispecialty Conference On PDD And DLBNational Institute Of Neurological Disorders And Stroke2006
- Dementia With Parkinsonism: What Are We Diagnosing?National Institute On Aging1998–1999
- Dementia With Parkinsonism: What Are We Diagnosing?National Institute On Aging1998
- UnknownNational Institute On Aging1996–1997
- Dementia With Parkinsonism--What Are We Diagnosing?National Institute On Aging1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
